Neuroendocrine Tumors of the Lung
-
Published:2016
Issue:
Volume:
Page:153-178
-
ISSN:
-
Container-title:Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances
-
language:
-
Short-container-title:
Publisher
Springer New York
Reference94 articles.
1. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.
2. Schiller JH, Harrington D, Belani CP, Eastern Cooperative Oncology Group, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92–8.
3. Emery IF, Battelli C, Auclair PL, et al. Response to gefitinib and erlotinib in non-small cell lung cancer: a retrospective study. BMC Cancer. 2009;9:333.
4. Modjtahedi H, Essapen S. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Anticancer Drugs. 2009;20(10):851–5.
5. Chong S, et al. Neuroendocrine tumors of the lung: clinical, pathologic, and imaging findings. Radiographics. 2006;26(1):41–57.